Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
AdvanSix
ASIX
$446M
| $13.1M | ﹤0.01% |
437,393
+24,543
| +6% | +$682K |
|
1852
AtriCure
ATRC
$2.21B
| $13.1M | ﹤0.01% |
367,151
+4,165
| +1% | +$155K |
|
1853
Camping World
CWH
$675M
| $13.1M | ﹤0.01% |
498,349
+28,569
| +6% | +$598K |
|
|
PRO
1854
DELISTED
PROS Holdings
PRO
| $13M | ﹤0.01% |
336,223
+4,057
| +1% | +$146K |
|
|
ADAM
1855
Adamas Trust
ADAM
$907M
| $13M | ﹤0.01% |
1,527,776
+132,162
| +9% | +$1.11M |
|
1856
Scorpio Tankers
STNG
$3.93B
| $13M | ﹤0.01% |
214,094
-8,502
| -4% | -$479K |
|
1857
Ginkgo Bioworks
DNA
$488M
| $12.9M | ﹤0.01% |
191,533
+6,073
| +3% | +$372K |
|
1858
Manitowoc
MTW
$753M
| $12.9M | ﹤0.01% |
773,565
+46,417
| +6% | +$675K |
|
|
KAMN
1859
DELISTED
Kaman Corp
KAMN
| $12.9M | ﹤0.01% |
538,146
-23
| -0% | -$476 |
|
1860
SiriusPoint
SPNT
$2.7B
| $12.8M | ﹤0.01% |
1,107,513
+32,395
| +3% | +$341K |
|
1861
Leslie's
LESL
$7.21M
| $12.8M | ﹤0.01% |
92,947
+10,054
| +12% | +$1.11M |
|
|
NOVA
1862
DELISTED
Sunnova Energy
NOVA
| $12.8M | ﹤0.01% |
842,130
+61,953
| +8% | +$678K |
|
|
RPT
1863
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $12.8M | ﹤0.01% |
999,089
-509,707
| -34% | -$5.8M |
|
1864
Ichor Holdings
ICHR
$2.67B
| $12.8M | ﹤0.01% |
380,515
+18,985
| +5% | +$526K |
|
1865
Thryv Holdings
THRY
$96.9M
| $12.7M | ﹤0.01% |
624,728
+130,107
| +26% | +$2.45M |
|
|
AVNS
1866
DELISTED
Avanos Medical
AVNS
| $12.6M | ﹤0.01% |
563,154
-7,288
| -1% | -$150K |
|
1867
Methode Electronics
MEI
$593M
| $12.6M | ﹤0.01% |
554,904
+64,055
| +13% | +$1.5M |
|
|
RCM
1868
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12.6M | ﹤0.01% |
1,192,722
+21,447
| +2% | +$243K |
|
1869
Pacira BioSciences
PCRX
$924M
| $12.5M | ﹤0.01% |
371,666
+11,696
| +3% | +$342K |
|
1870
Capitol Federal Financial
CFFN
$1.09B
| $12.5M | ﹤0.01% |
1,943,860
+150,482
| +8% | +$808K |
|
1871
Medifast
MED
$128M
| $12.5M | ﹤0.01% |
186,244
+20,034
| +12% | +$1.4M |
|
1872
Syndax Pharmaceuticals
SNDX
$1.7B
| $12.5M | ﹤0.01% |
577,022
+70,555
| +14% | +$1.08M |
|
|
PENG
1873
Penguin Solutions Inc
PENG
$3.12B
| $12.4M | ﹤0.01% |
655,702
+30,344
| +5% | +$525K |
|
|
CIM
1874
Chimera Investment
CIM
$993M
| $12.4M | ﹤0.01% |
826,286
+26,243
| +3% | +$396K |
|
1875
MGP Ingredients
MGPI
$389M
| $12.3M | ﹤0.01% |
124,998
-1,862
| -1% | -$179K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.